Use the Back button in your browser to see the other results of your search or to select another record.
Weight loss in obese Mexican Americans treated for 1-year with orlistat and lifestyle modification |
Poston WS, Reeves RS, Haddock CK, Stormer S, Balasubramanyam A, Satterwhite O, Taylor JE, Foreyt JP |
International Journal of Obesity and Related Metabolic Disorders 2003 Dec;27(12):1486-1493 |
clinical trial |
5/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: No; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
OBJECTIVE: To evaluate the effectiveness of a culturally appropriate lifestyle intervention combined with orlistat in producing weight loss with obese Mexican-American women. SUBJECTS: Mexican-American women (n = 108), aged 21 to 65 y, with a body mass index (BMI) >= 27 kg/m2 were randomized to 1 y of treatment with orlistat and a culturally tailored lifestyle modification intervention (OLM; n = 56) or a wait-list control group (WLC; n = 52). DESIGN: A randomized, controlled, open-label 12-month study. Orlistat was dosed at 120 mg, three times per day. The OLM intervention included behavior modification, a low-fat (<= 30% of total daily calories) diet, and moderate physical activity (>= 150 min/week). MEASUREMENT: Primary outcomes included changes in body weight (kg), BMI, waist circumference, blood pressure, glucose, and lipids. RESULTS: A total of 72 (37 OLM, 35 WLC) and 66 participants (32 OLM, 34 WLC) completed the 6- and 12-month follow-ups, respectively. Repeated-measures ANOVA demonstrated a significant time x treatment interaction (Wilks' lambda = 12.61; p < 0.001), indicating that OLM-treated patients achieved significant weight loss relative to the WLC group during the study (mean percentage weight loss +/- SEM; -8.1% +/- 1.2 versus -1.6% +/- 0.7 at 6 months and -8.8% +/- 1.5 versus -0.2% +/- 1.0 at 12 months, respectively). OLM-treated patients also experienced significant reductions in waist circumference, low-density-lipoprotein, and total cholesterol. CONCLUSIONS: This study demonstrates the effectiveness of an intervention combining orlistat and lifestyle modification with Mexican-American women, a population with substantial risk for obesity.
|